Neuronascent, Inc.

Neuronascent, Inc. is a biotechnology company developing small-molecule therapeutics aimed at generating new neurons and reversing neurological disorders such as Alzheimer's disease, Parkinson's disease, and developmental delay. The company's approach focuses on neurogenesis and neuron regeneration as a mechanism to address central nervous system conditions.